Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

This post-hoc analysis demonstrated an association between work productivity and stringent disease control criteria for those with psoriatic arthritis.

Strict Disease Control Criteria Linked to Increased Work Productivity for Patients with PsA

These data, presented at ACR 2024, demonstrate that response was maintained at 2 years among those with psoriatic arthritis who responded to bimekizumab at Week 16.

Bimekizumab Maintains Efficacy for PsA Up to 2 Years Among Week 16 Responders

Gossec discussed findings from the PsABIOnd study presented at the 2024 ACR Convergence.

Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis

Schett discussed findings from 2 early studies of CD19 CAR T-cell therapy.

Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD

People who used GC for over 2 years and 3 years had elevated risks of CVD and infection-related mortality, respectively, that never returned to pre-GC use levels.

Glucocorticosteroid Use for Rheumatoid Arthritis Increases CVD, Infection Mortality Risk Even After Cessation 

People with diabetes, kidney stones, damaged joints, high uric acids, and daily use of NSAID were more likely to develop CKD than others.

People With Psoriatic Arthritis at Risk For Chronic Kidney Disease

A new cohort study including over 6 million participants has found an increased likelihood of Behçet disease, alocpecia, bulbous pemphigoid and other disorders post-COVID infection.

Autoimmune/Inflammatory Tissue Disorders Associated With COVID-19 Infection

The international phase 4 MOSAIC study is the first evaluating PsAMRIS and MRI-WIPE outcomes in patients with psoriatic arthritis.

Whole-Body MRIs Reveal PsA Inflammation Improvements With Apremilast

The rheumatology month in review emphasizes new data on secukinumab, gout clinical decision making, and addressing sleep issues in fibromyalgia.

Rheumatology Month in Review: October 2024

Patients exposed to screening were also more likely to receive vaccinations and consult a cardiologist and/or a pneumologist.

Multimorbidity Screening Reduced Hospitalizations in Patients With Rheumatic Diseases

On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.